A2A-O-06

N/A

Report date: 2022/02/18 10:23:46
NME

Base Information

Drug NameA2A-O-06
Drug Alias NameA2A-O-06A2A_O-06
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesA2A Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesA2A Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A